Radiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer

Clinical trial NCT00089245 · TERMINATED

Trial details

NCT number: NCT00089245
Sponsor: Y-mAbs Therapeutics
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors Neuroblastoma Sarcoma

Start date: 2004-02-05
Primary completion: 2022-02-02
Enrollment: 177

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.